Skip to content

Individualized treatment for Helicobacter pylori infection in Jiangsu Province

Individualized treatment for Helicobacter pylori infection in Jiangsu Province

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027743
Enrollment
Unknown
Registered
2019-11-24
Start date
2015-05-01
Completion date
Unknown
Last updated
2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori infection

Interventions

2:Individualized treatment for Helicobacter pylori infection

Sponsors

Jiangsu Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 ~ 70 years old, male or female; 2. visit the doctor for discomfort symptoms such as abdominal pain, abdominal distension, regurgitation, belching, nausea, vomiting, heartburn, chest pain, etc.; 3. no antibiotics, bismuth, H2 receptor antagonist or PPI preparation were given within the last 4 weeks; 4. positive 13C urea breath test; 5. agree to perform gastroscopy and take gastric mucosa biopsy specimens for HP culture, drug sensitivity test and other experiments related to this study; 6. HP infected patients who agree to the eradication treatment of HP, and are willing to cooperate with doctors to conduct follow-up investigation on the efficacy of eradication; 7. sign informed consent voluntarily.

Exclusion criteria

Exclusion criteria: 1. patients who failed to eradicate helicobacter pylori treatment; 2. patients with contraindicated gastric mucosal biopsy (coagulation dysfunction, taking anticoagulant drugs, etc.); 3. serious impairment of heart, liver and kidney function; 4. pregnant or lactating women; 5. hematemesis, black stool, perforation, pyloric obstruction, cancer complications; 6. patients with a history of esophageal and gastrointestinal surgery; 7. patients who cannot properly express their main complaints, such as mental illness or severe neurosis; 8. those who take nonsteroidal anti-inflammatory drugs or alcohol at the same time; 9. allergic to any of the 6 antibiotics (amoxicillin, metronidazole, clarithromycin, levofloxacin, tetracycline, furazolidone) in the HP drug sensitivity test.

Design outcomes

Primary

MeasureTime frame
Ind Helicobacter pylori infection;

Countries

China

Contacts

Public ContactFeng Ye

Department of Gastroenterology, The First Affliated Hospital of Nanjing Medical University

1044450463@qq.com+86 17366358576

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 26, 2026